NeutralLOW severityHealthcare & Pharma6h ago

Tilray Brands in downtrend: Bearish signals defy Wall Street's 'Buy' call

Tilray Brands in downtrend: Bearish signals defy Wall Street's 'Buy' call — $TLRY one-month chart
$TLRY daily closes over the past month · Wook of Wall Street artwork from market data

At a glance

WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Ask about TLRY. Get explanations, comparisons and calculations with the source lookups shown.

Risk check · tilray brandsEvent risk Low

Nothing reported about tilray brands across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.

From here · last month’s volatility 65% a year
Now $2.35Week $2.13–$2.57 (±9.2%)Month $1.91–$2.79 (±18.8%)
Ask Wook AI

Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.

Wook analysis

What it means

Key points
  • What to watch: Policy moves the whole healthcare aisle; trial data moves one company. Knowing which kind of story this is helps.
  • How the stock is trading: $TLRY +0.43% in the latest session.
  • Timing: It came out during market hours, so traders could react the same day, and the session move may reflect that.

Where the stock stands

Tilray Brands ($TLRY) ticked up 0.43% to $2.35 in the latest session. Over the past month it is down 22.4%. That leaves it 85% below its 52-week high of $15.70 and 2.2% above its low of $2.30, close to the bottom of its range. It has been a volatile year: the high was 6.8 times the low, so moves this size are not unusual for it.

What the filings say

In its latest report (10-Q, filed Oct 8, 2026), $TLRY lost $43.1M over the quarter to Aug 31, 2026 on revenue of $257.1M. Operations used $16.5M of cash over the quarter to Aug 31, 2026 — about $5.5M a month — against $215.0M in cash on Aug 31, 2026. At that pace the cash covers about 3.3 years. It carried $118.0M of debt against $215.0M of cash on Aug 31, 2026 — net cash of $96.9M. Its most recent filings before this story: 10-Q on Oct 8, 2026, 8-K on Oct 8, 2026, 8-K on Sep 14, 2026. Figures are as filed with the SEC; the $TLRY page has the full statements.

How much coverage it is getting

Wook has no other story on Tilray Brands from the last 30 days, so there is no recent run to compare this one with.

The bigger picture

In healthcare, the calendar is the catalyst — trial readouts, FDA decisions and pricing rules. One result can move a single drugmaker sharply; a policy change moves the whole aisle. Wook's supply-chain scanner shows no unusual stress in Health Care today.

Coming up

Monthly options expiration in 3 days and FOMC decision in 22 days. These dates were set well before this story broke. The nearest is 3 days away, so fresh numbers are close.

What to watch next

For the company's side of it, read its latest SEC filings on the $TLRY page. A US company has to report material news on an 8-K, usually within four business days; foreign issuers use a 6-K. Where several outlets agree is usually the news; where they differ is the angle. To run the numbers yourself, ask Wook AI above about $TLRY: its distance from the high, its last report, or how coverage has changed.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Seeking Alpha published this on November 17, 2026. $TLRY has moved +0.43% ($2.34 to $2.35). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.

Choose what Wook may measure. Essential sign-in and security cookies stay on.

Read the privacy policy